Back to Journals » OncoTargets and Therapy » Volume 15

Forkhead Box Protein A1 is a Prognostic Predictor and Promotes Tumor Growth of Gastric Cancer [Retraction]

Authors Ren H, Zhang P, Tang Y, Wu M, Zhang W

Received 26 July 2022

Accepted for publication 26 July 2022

Published 29 July 2022 Volume 2022:15 Pages 829—830

DOI https://doi.org/10.2147/OTT.S383786



Ren H, Zhang P, Tang Y, Wu M, Zhang W. Onco Targets Ther. 2015;8:3029–3039.

At the authors request, the Editor and Publisher of OncoTargets and Therapy wish to retract the published article. The authors requested a retraction due to the lack of reproducibility of the results described in Figure 7. However, the authors were unable to provide any original data for their study and could not explain the alleged duplication of western blot images in Figures 5 and 7. Specifically,

  • Western blot bands for Figure 5B, FOXA1 and GAPDH, appear to have been duplicated with western blot bands for Figure 7D, YAP and GAPDH.

The Editor agreed with the decision to retract the paper.

Our decision-making was informed by our policy on publishing ethics and integrity and the COPE guidelines on retraction.

The retracted article will remain online to maintain the scholarly record, but it will be digitally watermarked on each page as “Retracted”.


This retraction relates to this paper


Creative Commons License © 2022 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.